Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Efstathiou

Showing results (61-70 of 278) with videos related to

Pageof 28
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Differences in Quality of Life Between Men and Women who Undergo Bladder Preservation with Trimodality TherapyLeslie K Ballas, Andrzej Niemierko, Kimberley S Mak, et al.
JAMA|July 17, 2019
Association Between Declared Hurricane Disasters and Survival of Patients With Lung Cancer Undergoing Radiation TreatmentLeticia M Nogueira, Liora Sahar, Jason A Efstathiou, et al.
Radiation Oncology (London, England)|November 8, 2017
Multicriteria plan optimization in the hands of physicians: a pilot study in prostate cancer and brain tumorsBirgit S Müller, Helen A Shih, Jason A Efstathiou, et al.
Medical Physics|July 5, 2013
Hypofractionated proton therapy for prostate cancer: dose delivery uncertainty due to interfractional motionYi Wang, Jason A Efstathiou, Hsiao-Ming Lu, et al.
The New England Journal of Medicine|January 17, 2014
Case records of the Massachusetts General Hospital. Case 2-2014. A 44-year-old man with a lesion on the penisW Scott McDougal, Richard J Lee, Jason A Efstathiou, et al.
World Journal of Radiology|May 10, 2016
Quantitative study of prostate cancer using three dimensional fiber tractographySandeep Hedgire, Alexey Tonyushkin, Aoife Kilcoyne, et al.
Acta Oncologica (Stockholm, Sweden)|July 20, 2021
Proton vs. photon radiotherapy for MR-guided dose escalation of intraprostatic lesionsMaryam Moteabbed, Mukesh Harisinghani, Harald Paganetti, et al.
European Urology|September 7, 2016
Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate CancerPhillip J Gray, Chun Chieh Lin, Matthew R Cooperberg, et al.
BJU International|April 17, 2026
Alternatives to radical cystectomy: a bladder-sparing approach in appropriately selected patientsJosé I Nolazco, Kevin R Melnick, Richard J Lee, et al.
The Lancet. Oncology|December 4, 2018
Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancerDavid T Miyamoto, Kent W Mouw, Felix Y Feng, et al.
Pageof 28

Showing results (61-70 of 278) with videos related to

Sort By:
Pageof 28
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Differences in Quality of Life Between Men and Women who Undergo Bladder Preservation with Trimodality TherapyLeslie K Ballas, Andrzej Niemierko, Kimberley S Mak, et al.
JAMA|July 17, 2019
Association Between Declared Hurricane Disasters and Survival of Patients With Lung Cancer Undergoing Radiation TreatmentLeticia M Nogueira, Liora Sahar, Jason A Efstathiou, et al.
Radiation Oncology (London, England)|November 8, 2017
Multicriteria plan optimization in the hands of physicians: a pilot study in prostate cancer and brain tumorsBirgit S Müller, Helen A Shih, Jason A Efstathiou, et al.
Medical Physics|July 5, 2013
Hypofractionated proton therapy for prostate cancer: dose delivery uncertainty due to interfractional motionYi Wang, Jason A Efstathiou, Hsiao-Ming Lu, et al.
The New England Journal of Medicine|January 17, 2014
Case records of the Massachusetts General Hospital. Case 2-2014. A 44-year-old man with a lesion on the penisW Scott McDougal, Richard J Lee, Jason A Efstathiou, et al.
World Journal of Radiology|May 10, 2016
Quantitative study of prostate cancer using three dimensional fiber tractographySandeep Hedgire, Alexey Tonyushkin, Aoife Kilcoyne, et al.
Acta Oncologica (Stockholm, Sweden)|July 20, 2021
Proton vs. photon radiotherapy for MR-guided dose escalation of intraprostatic lesionsMaryam Moteabbed, Mukesh Harisinghani, Harald Paganetti, et al.
European Urology|September 7, 2016
Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate CancerPhillip J Gray, Chun Chieh Lin, Matthew R Cooperberg, et al.
BJU International|April 17, 2026
Alternatives to radical cystectomy: a bladder-sparing approach in appropriately selected patientsJosé I Nolazco, Kevin R Melnick, Richard J Lee, et al.
The Lancet. Oncology|December 4, 2018
Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancerDavid T Miyamoto, Kent W Mouw, Felix Y Feng, et al.
Pageof 28